Mpox primer for clinicians: what makes the difference in 2024?

By sjmartinez • January 16, 2025

Abdel-Rahman SM, Bayıcı BZ, Keske Ş, Kuşkucu M, Özsürekçi Y, Rimoin AW, Rodriguez-Morales AJ, Ergönül Ö. Mpox primer for clinicians: what makes the difference in 2024? Curr Opin Infect Dis. 2025 Jan 16. doi: 10.1097/QCO.0000000000001091. Epub ahead of print. PMID: 39813011.

Tags: Infectious Diseases, Publications

Hybrid strategy of coronary atherosclerosis characterization with T1-weighted MRI and CT angiography to noninvasively predict periprocedural myocardial injury

Matsumoto H, Higuchi S, Li D, Tanisawa H, Isodono K, Irie D, Ohya H, Kitamura R, Kaneko K, Nakazawa M, Suzuki K, Komori Y, Hondera[...]

Repercussions of the COVID- 19 pandemic on maternal and congenital syphilis in South Brazil: a time series analysis 2010-2022

Echegaray F, Hernandez CJ, Sundar KG, Yang LZ, Cambou MC, Segura ER, de Melo MG, Santos BR, Dos Santos Varella IR, Nielsen-Saines K. Repercussions of[...]

Disseminated coccidioidomycosis presenting as eosinophilic ascites

Fetters KB, Fernandez-Hazoury D, Grujic S, Lee P. Disseminated coccidioidomycosis presenting as eosinophilic ascites. BMJ Case Rep. 2025 Apr 15;18(4):e263734. doi: 10.1136/bcr-2024-263734. PMID: 40234081.